Pneumonia Due to Cryptococcus neoformans in a Patient Receiving Infliximab: Possible Zoonotic Transmission From a Pet Cockatiel

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Respiratory care

• Publication date

  2004-06-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.4187/respcare.04490606PMID 15165294
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Benefit-Risk Assessment of Infliximab in the Treatment of Rheumatoid Arthritis

  2003cited by this paper
• Pulmonary Cryptococcosis After Initiation of Anti-Tumor Necrosis Factor-α Therapy

  2003cited by this paper
• Tumor Necrosis Factor-α Blockade: A Novel Therapy for Rheumatic Disease

  2002cited by this paper
• Disseminated cryptococcal infection in rheumatoid arthritis treated with methotrexate and infliximab.

  2002cited by this paper
• Invasive pulmonary aspergillosis associated with infliximab therapy.

  2001cited by this paper
• Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

  2001cited by this paper
• Evidence of Zoonotic Transmission of Cryptococcus neoformans from a Pet Cockatoo to an Immunocompromised Patient

  2000cited by this paper
• Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans.

  1996cited by this paper
• Cryptococcal meningitis after unusual exposures to birds.

  1993cited by this paper
• The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis.

  1991cited by this paper

• Cryptococcosis Associated With Biologic Therapy: A Narrative Review

  2024cites this paper
• Similar evolutionary trajectories in an environmental Cryptococcus neoformans isolate after human and murine infection

  2023cites this paper
• Coronavirus Pandemic Cryptococcal meningitis post-COVID-19 infection: Immunomodulation, a double-edged sword

  2023cites this paper
• Cryptococcal Meningitis in an Immunocompetent Man Exposed to a Pet Cockatoo: An Overlooked Zoonosis

  2022cites this paper
• Characteristics of pulmonary cryptococcosis in patients with rheumatoid arthritis

  2021cites this paper
• COVID-19-associated opportunistic infections: a snapshot on the current reports

  2021cites this paper
• Management of Cryptococcosis in Transplant Candidates and Recipients

  2021cites this paper
• Cryptococcosis.

  2021cites this paper
• Possible environmental exposure-associated pulmonary cryptococcosis in a patient with rheumatoid arthritis: a case report and literature review

  2020cites this paper
• Fungal Infections Potentiated by Biologics.

  2020cites this paper
• Dormancy in Cryptococcus neoformans: 60 years of accumulating evidence.

  2020cites this paper
• Evaluation of bacterial and fungal communities during the fermentation of Baixi sufu, a traditional spicy fermented bean curd.

  2019cites this paper
• One Health and Parasites

  2019cites this paper
• Fungal infections following treatment with monoclonal antibodies and other immunomodulatory therapies.

  2019cites this paper
• Pets in modern society: hidden threats.

  2018cites this paper
• Case Series: Report of the First Two Human Indigenous Cases of Cryptococcus gattii Infection in Eastern Canada

  2018cites this paper
• Zweiter österreichischer Konsensus zur sicheren Anwendung von anti-TNF-α-Antikörpern bei chronisch-entzündlichen Darmerkrankungen

  2018cites this paper
• Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis.

  2017cites this paper
• Cryptococcal Lung Infections.

  2017cites this paper
• Serious infection during etanercept, infliximab and adalimumab therapy for rheumatoid arthritis: A literature review

  2016cites this paper
• Opportunistic Infections and Autoimmune Diseases

  2015cites this paper
• Pulmonary Cryptococcosis in Rheumatoid Arthritis Patient Treated With Leflunomide

  2014cites this paper
• Immunocompromised patients and their pets: still best friends?

  2013cites this paper
• Frequency of Monotherapy versus Combination Therapy in Reported Cases of Infections Occurring in the Setting of Biologic Agents

  2013cites this paper
• Cryptococcus antigens and immune responses: implications for a vaccine

  2013cites this paper
• Possible pulmonary cryptococcosis in a patient with Crohn's disease during anti-tumor necrosis factor-alpha treatment: a case report and literature review.

  2012cites this paper
• Laboratory and Epidemiology Communications Possible Pulmonary Cryptococcosis in a Patient with Crohn's Disease during Anti-Tumor Necrosis Factor-Alpha Treatment: a Case Report and Literature Review

  2012cites this paper
• An official American Thoracic Society statement: Treatment of fungal infections in adult pulmonary and critical care patients.

  2011cites this paper
• Cryptococcus neoformans: Latency and Disease

  2011cites this paper
• The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organisation: Safety

  2011cites this paper
• Asymptomatic pulmonary cryptococcosis in a patient with Crohn's disease on infliximab: case report.

  2011cites this paper
• Interaction of Cryptococcus neoformans and Cryptococcus gattii with the host immune system

  2010cites this paper
• Anforderungen an die Hygiene bei der medizinischen Versorgung von immunsupprimierten Patienten

  2010cites this paper
• A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease.

  2010cites this paper
• [Non tuberculous anti-TNF associated opportunistic infections].

  2010cites this paper
• Pityrosporum folliculitis in a Crohn's disease patient receiving infliximab.

  2010cites this paper
• Isolation of Cryptococcus neoformans in Dry Droppings of Captive Birds in Santiago, Chile

  2010cites this paper
• Infections opportunistes non tuberculeuses au cours des traitements par les anti-TNFα

  2010cites this paper
• A Pityrosporum Fungal Infection Following Infliximab Therapy in a Crohn's Disease Patient

  2010cites this paper
• Detección de levaduras en cloaca de dos especies psitácidas nativas en un centro de rehabilitación en Chile

  2010cites this paper
• Suscetibilidade in vitro e alterações morfologicas em células melanizadas e não melanizadas na presença de voriconazol, anfotericina B e extrato bruto da folha de P. pseudocaryophyllus (Gomes) L. R. Landrum

  2010cites this paper
• Incidence and nature of infectious disease in patients treated with anti-TNF agents.

  2009cites this paper
• Disseminated Cryptococcal Infection and Anti-Tumor Necrosis Factor-α Treatment for Refractory Sarcoidosis: An Expected Association?

  2009cites this paper
• Disseminated Cryptococcal Infection and Anti-Tumor Necrosis Factor- α Treatment for Refractory Sarcoidosis:

  2009cites this paper
• Invasive fungal infections in the era of biologics.

  2009cites this paper
• Infections Related to Steroids in Immunosuppressive/Immunomodulating Agents in Critical Care

  2009cites this paper
• Diversity of the Cryptococcus neoformans-Cryptococcus gattii species complex.

  2008cites this paper
• Fungal Infections Complicating Tumor Necrosis Factor α Blockade Therapy

  2008cites this paper
• Disseminated Cryptococcus neoformans after treatment with infliximab for rheumatoid arthritis.

  2008cites this paper
• La paloma y otras aves como reservorio de Cryptococcus spp.

  2008cites this paper
• [Pigeons and other birds as a reservoir for Cryptococcus spp].

  2008cites this paper
• Fungal infections complicating tumor necrosis factor alpha blockade therapy.

  2008cites this paper
• A 61-year-old man with asymptomatic, bilateral lung masses.

  2008cites this paper
• Pneumocystis jiroveci (carinii) Pneumonia After Infliximab Therapy: A Review of 84 Cases

  2007cites this paper
• Determining Risk Factors for Infection with Influenza A (H5N1)

  2007cites this paper
• Cryptococcal meningitis in a patient treated with infliximab.

  2007influential citation
• Invasive Cryptococcosis and Adalimumab Treatment

  2007cites this paper
• 37 - Drugs that act on the immune system: Cytokines and monoclonal antibodies

  2007cites this paper
• Pulmonary abnormalities in inflammatory bowel disease.

  2007cites this paper
• Invasive Trichophyton Rubrum Infection Occurring with Infliximab and Long-Term Prednisone Treatment

  2007cites this paper
• A Case of Cryptococcal Pneumonia in a Rheumatoid Arthritis Patient after Tumor Necrosis Factor-alpha Antagonist Therapy

  2007cites this paper
• Impact of biologic agents on infectious diseases.

  2006cites this paper
• Meningitis criptocócica tras tratamiento con etanercept

  2006cites this paper
• [Cerebral cryptococcosis associated with etanercept].

  2006cites this paper
• Problems encountered during anti-tumour necrosis factor therapy.

  2006cites this paper
• The Physical Properties of the Capsular Polysaccharides from Cryptococcus neoformans Suggest Features for Capsule Construction*

  2006cites this paper
• Safety of infliximab and other biologic agents in the inflammatory bowel diseases.

  2006cites this paper
• Confronting Zoonoses, Linking Human and Veterinary Medicine

  2006cites this paper
• Development of leprosy and type 1 leprosy reactions after treatment with infliximab: a report of 2 cases.

  2006cites this paper
• Cutaneous cryptococcosis in a donkey

  2006cites this paper
• Clinical applications of the polymerase chain reaction: an update.

  2006cites this paper
• Infections Associated with Tumor Necrosis Factor‐α Antagonists

  2005cites this paper
• Infections Associated With Tumor Necrosis Factor-α Antagonists

  2005cites this paper
• First Case of Human Cryptococcosis Due to Cryptococcus neoformans var. gattii in Spain

  2005cites this paper
• Tumor necrosis factor antagonists and infections: the small print on the price tag.

  2005cites this paper
• Zoonotic transmission of Cryptococcus neoformans from a magpie to an immunocompetent patient

  2005cites this paper
• Exogenous administration of immunomodulatory therapies in hematopoietic cell transplantation: an infectious diseases perspective

  2005cites this paper
• Disseminated aspergillosis following infliximab therapy in an immunosuppressed patient with Crohn's disease and chronic hepatitis C: a case study and review of the literature.

  2005cites this paper
• Feasibility and prospects for a vaccine to prevent cryptococcosis.

  2005cites this paper
• Infekte bei rheumatischen Erkrankungen

  2005cites this paper
• Infections associated with tumor necrosis factor-alpha antagonists.

  2005cites this paper
• , European Blastomycosis , Busse-Buschke ’ s Disease

  2005cites this paper
• Infections associated with tumor necrosis factor-alpha antagonists.

  2005cites this paper
• A comprehensive review and evaluation of the side effects of the tumor necrosis factor alpha blockers etanercept, infliximab and adalimumab

  2004cites this paper
• Author Index to Volume 49 (2004)

  2004cites this paper
• INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES

  year unknowncites this paper